In another investigation, CIK cells sensitized by EpCAM and CD44 peptide DCs were effective in vitro against Prostate Cancer Stem like Cell (PCSC)-enriched prostate-spheroids and in vivo against PCSC-enriched prostate-spheroid xenografts [194]. The gene discussed is EPCAM; the disease is prostate cancer.